Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tuberculosis, Multidrug-resistant”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Not applicableStudy completedNCT02727582
What this trial is testing

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

Who this might be right for
Multidrug-resistant Tuberculosis
University of Cape Town 142
Not applicableActive Not RecruitingNCT05871489
What this trial is testing

Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens

Who this might be right for
Tuberculosis, Multidrug-ResistantHIV
Harvard Medical School (HMS and HSDM) 800
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Not applicableNot Yet RecruitingNCT06700577
What this trial is testing

Multidrug Resistance in Newly Diagnosed TB Patient

Who this might be right for
Tuberculosis
Assiut University 100
Not applicableStudy completedNCT07135622
What this trial is testing

Xpert MTB/RIF Ultra Trial

Who this might be right for
Tuberculosis (TB)Pulmonary TB
Nestani Tukvadze 778
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Post-approval studies (Phase 4)Study completedNCT00495339
What this trial is testing

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Sanofi 100
Large-scale testing (Phase 3)Study completedNCT01061593
What this trial is testing

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Who this might be right for
TuberculosisHIV
Lisichansk Regional Tuberculosis Dispensary 269
Not applicableStudy completedNCT02413931
What this trial is testing

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 53
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableNot Yet RecruitingNCT05007795
What this trial is testing

Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
University of Cape Town 280
Early research (Phase 1)Study completedNCT02503839
What this trial is testing

Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic

Who this might be right for
Tuberculosis
Anne Margarita Dyrhol Riise 39
Not applicableStudy completedNCT04119375
What this trial is testing

Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes

Who this might be right for
TuberculosisAdherence, PatientAdherence, Medication+1 more
Massachusetts Institute of Technology 16,146
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Not applicableStudy completedNCT03728725
What this trial is testing

Xpert MTB/XDR Clinical Evaluation Trial

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 710
Not applicableStudy completedNCT02715271
What this trial is testing

Study of TB Lesions Obtained in Therapeutical Surgery

Who this might be right for
TuberculosisThoracic SurgeryTuberculosis, Pulmonary+1 more
Fundació Institut Germans Trias i Pujol 192
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT02354014
What this trial is testing

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Research & Development, LLC 60
Load More Results